|
FRS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.258900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.806800E-04 |
| Normal-vs-Stage2 |
3.621600E-02 |
| Normal-vs-Stage3 |
8.261600E-02 |
| Normal-vs-Stage4 |
3.541800E-01 |
| Stage1-vs-Stage2 |
9.851600E-01 |
| Stage1-vs-Stage3 |
6.669000E-01 |
| Stage1-vs-Stage4 |
9.330000E-01 |
| Stage2-vs-Stage3 |
7.105800E-01 |
| Stage2-vs-Stage4 |
9.544000E-01 |
| Stage3-vs-Stage4 |
8.567400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.359700E-04 |
| Normal-vs-AfricanAmerican |
2.114600E-01 |
| Normal-vs-Asian |
1.899970E-02 |
| Caucasian-vs-AfricanAmerican |
3.251800E-01 |
| Caucasian-vs-Asian |
7.895000E-01 |
| AfricanAmerican-vs-Asian |
5.650600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.401900E-04 |
| Normal-vs-Female |
4.353200E-01 |
| Male-vs-Female |
7.361500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.076100E-02 |
| Normal-vs-Extreme_Weight |
3.61410000004891E-06 |
| Normal-vs-Obese |
1.003810E-01 |
| Normal-vs-Extreme_Obese |
1.252480E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.422600E-01 |
| Normal_Weight-vs-Obese |
3.891400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.029600E-01 |
| Extreme_Weight-vs-Obese |
2.457800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.004000E-01 |
| Obese-vs-Extreme_Obese |
1.744570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.407800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.004400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.183400E-04 |
| Normal-vs-Age(81-100Yrs) |
6.33869999999703E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.139200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.379700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.518100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.504300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.331980E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.020200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.855700E-03 |
| Normal-VS-Type2 PRCC |
2.030800E-04 |
| Normal-VS-KIRP CIMP |
3.926400E-01 |
| Normal-VS-Unclassified PRCC |
8.918600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.061200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.861000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.394420E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.587000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.418080E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.359600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.09599999999988E-05 |
| Normal-vs-N1 |
8.881800E-01 |
| Normal-vs-N2 |
2.453800E-02 |
| N0-vs-N1 |
7.916100E-02 |
| N0-vs-N2 |
9.950200E-01 |
| N1-vs-N2 |
4.431600E-01 |
|
|
